All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study. [electronic resource]
Producer: 20171024Description: 1433-41 p. digitalISSN:- 1478-3231
- Administration, Oral
- Adult
- Aged
- Alanine Transaminase -- blood
- Antiviral Agents -- administration & dosage
- Asian People
- Carbamates
- Double-Blind Method
- Drug Resistance, Viral -- genetics
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Imidazoles -- administration & dosage
- International Cooperation
- Isoquinolines -- administration & dosage
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- Pyrrolidines
- RNA, Viral -- blood
- Sulfonamides -- administration & dosage
- Sustained Virologic Response
- Valine -- analogs & derivatives
- Viral Load
- Viral Nonstructural Proteins -- genetics
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.